FDA approves nivolumab-ipilimumab combination for melanoma
Topical fluorouracil shows long-term benefit for actinic keratoses
Melanoma regression a positive prognostic indicator
Immune-related patterns of response present challenges
Point/Counterpoint: What is the first-line treatment of choice for metastatic BRAF-mutant melanoma?
Mini X-Ray Device Treats Nonmelanoma Skin Cancers
VIDEO: Dual immunotherapy more powerful in melanoma, but where do we go from here?
VIDEO: Lymphadenectomies don’t boost survival in melanoma with SLN micrometastases
VIDEO: Updating the immune response to nonmelanoma skin cancer